-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

How to Avoid Early Mortality in APL

Program: Education Program
Session: Hematologists as Lifesavers: Inpatient Hematology Emergencies
Hematology Disease Topics & Pathways:
Acute Myeloid Malignancies, APL, Diseases, Myeloid Malignancies
Monday, December 11, 2023, 4:30 PM-5:45 PM

Martin S. Tallman, MD

Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL

Disclosures: Tallman: AbbVie: Research Funding; Orsenix: Research Funding; BioSight: Research Funding; Glycomimetics: Research Funding; Rafael Pharmaceuticals: Research Funding; Amgen: Research Funding; Innate Pharmaceuticals: Consultancy; Ipsen Biopharmaceuticalas: Consultancy; Kura: Consultancy; Novartis: Consultancy; American Society of Hematology: Honoraria, Membership on an entity's Board of Directors or advisory committees; HOVON: Membership on an entity's Board of Directors or advisory committees; Foghorn: Membership on an entity's Board of Directors or advisory committees; UpToDate: Patents & Royalties.

See more of: Hematologists as Lifesavers: Inpatient Hematology Emergencies
See more of: Education Program
Previous Presentation | Next Presentation >>